Alpha Cubed Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-802
Closed -$206K 282
2023
Q3
$206K Buy
+802
New +$215K 0.01% 237
2022
Q3
Sell
-2,000
Closed -$408K 266
2022
Q2
$408K Sell
2,000
-2
-0.1% -$409 0.03% 188
2022
Q1
$422K Buy
+2,002
New +$435K 0.03% 212
2018
Q4
Sell
-2,172
Closed -$696K 233
2018
Q3
$696K Buy
+2,172
New +$748K 0.08% 130

Other funds holding BIIB

Alpha Cubed Investments's BIIB Position: Q4 2023 in Review

Alpha Cubed Investments sold out of Biogen (BIIB) in Q4 2023, closing a stake of 802 shares — an estimated $206K sold.

Alpha Cubed Investments first reported a position in BIIB in Q3 2018 and held it in 4 quarters. The position peaked at $696K in Q3 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Alpha Cubed Investments reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Alpha Cubed Investments sold 802 Biogen shares in Q4 2023, an estimated $206K.
  • Alpha Cubed Investments first reported a position in Biogen in Q3 2018 and held it in 4 quarters.
  • Alpha Cubed Investments's Biogen position peaked at $696K in Q3 2018.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Alpha Cubed Investments's 13F filing for Q4 2023, filed 5 Feb 2024.